CEO of Tylenol Maker Lobbied RFK Jr. Not to Cite Drug as Autism Cause in Report

Kirk Perry, the interim CEO of Tylenol maker Kenvue, had a private meeting with Robert F. Kennedy Jr. this week to deliver a message: There is no clear link between the drug and autism.

In a hastily scheduled meeting, Perry sought to dissuade the health secretary from including the over-the-counter medication as a potential cause in a coming report about the causes of autism, according to a person familiar with the matter.